國立虎尾科技大學 |

A Mixed Methods Approach to Understanding Financial Toxicity in Management of Advanced Prostate Cancer.

紀錄類型:	書目-語言資料,手稿 : Monograph/item
正題名/作者:	A Mixed Methods Approach to Understanding Financial Toxicity in Management of Advanced Prostate Cancer./
作者:	Joyce, Daniel D.
面頁冊數:	1 online resource (95 pages)
附註:	Source: Masters Abstracts International, Volume: 85-03.
Contained By:	Masters Abstracts International85-03.
標題:	Oncology. -
電子資源:	click for full text (PQDT)
ISBN:	9798380321808

A Mixed Methods Approach to Understanding Financial Toxicity in Management of Advanced Prostate Cancer.
Joyce, Daniel D.

A Mixed Methods Approach to Understanding Financial Toxicity in Management of Advanced Prostate Cancer. - 1 online resource (95 pages)

Source: Masters Abstracts International, Volume: 85-03.

Thesis (M.BIO.Med.S.)--College of Medicine - Mayo Clinic, 2023.

Includes bibliographical references

Purpose: Assessments of financial toxicity among patients with metastatic prostate cancer are lacking. Using patient surveys, we sought to identify coping mechanisms and assess characteristics associated with lower financial toxicity.Materials and methods: Surveys were administered to all patients seen at a single center's Advanced Prostate Cancer Clinic over a three-month period. Surveys included the COmprehensive Score for Financial Toxicity (COST-FACIT) and coping mechanism questionnaires. Patients with metastatic disease (lymph nodes, bone, visceral) were included for analysis. Coping mechanisms were compared between patients experiencing low (COST-FACIT>24) versus high (COST-FACIT≤24) financial toxicity using Fisher's exact test. Multivariable linear regression was used to evaluate characteristics associated with lower financial toxicity.Results: Overall, 281 patients met inclusion criteria of which 79 reported high financial toxicity. In multivariable analysis, characteristics associated with lower financial toxicity included older age (estimate:0.36, 95%CI:0.21-0.52), applying for patient assistance programs (estimate:4.42, 95%CI:1.72-7.11), and an annual income of at least $100,000 (estimate:7.81, 95%CI:0.97,14.66). Patients with high financial toxicity were more likely to decrease spending on basic goods (35% vs. 2.5%, p0.001), as well as use savings (62% vs. 17%, p<0.001) to pay for their treatment.Conclusions: In this cross-sectional study, patients with metastatic prostate cancer and high financial toxicity were more likely to decrease spending on basic goods and leisure activities and use savings to pay for care. Understanding the impact of financial toxicity on patients' lives is crucial to inform shared decision-making and interventions designed to mitigate financial toxicity in this population.

Electronic reproduction.
Ann Arbor, Mich. :
ProQuest,
2024

Mode of access: World Wide Web

ISBN: 9798380321808Subjects--Topical Terms:

593951
Oncology.
Subjects--Index Terms:

Financial toxicityIndex Terms--Genre/Form:

554714
Electronic books.

A Mixed Methods Approach to Understanding Financial Toxicity in Management of Advanced Prostate Cancer.
LDR:03251ntm a22003977 4500 001 1152603
005 20241209114607.5
006 m o d
007 cr mn ---uuuuu
008 250605s2023 xx obm 000 0 eng d
020 $a 9798380321808
035 $a (MiAaPQ)AAI30639261
035 $a AAI30639261
040 $a MiAaPQ $b eng $c MiAaPQ $d NTU
100 1 $a Joyce, Daniel D. $3 1479645
245 1 2 $a A Mixed Methods Approach to Understanding Financial Toxicity in Management of Advanced Prostate Cancer.
264 0 $c 2023
300 $a 1 online resource (95 pages)
336 $a text $b txt $2 rdacontent
337 $a computer $b c $2 rdamedia
338 $a online resource $b cr $2 rdacarrier
500 $a Source: Masters Abstracts International, Volume: 85-03.
500 $a Advisor: Boorjian, Stephen A.
502 $a Thesis (M.BIO.Med.S.)--College of Medicine - Mayo Clinic, 2023.
504 $a Includes bibliographical references
520 $a Purpose: Assessments of financial toxicity among patients with metastatic prostate cancer are lacking. Using patient surveys, we sought to identify coping mechanisms and assess characteristics associated with lower financial toxicity.Materials and methods: Surveys were administered to all patients seen at a single center's Advanced Prostate Cancer Clinic over a three-month period. Surveys included the COmprehensive Score for Financial Toxicity (COST-FACIT) and coping mechanism questionnaires. Patients with metastatic disease (lymph nodes, bone, visceral) were included for analysis. Coping mechanisms were compared between patients experiencing low (COST-FACIT>24) versus high (COST-FACIT≤24) financial toxicity using Fisher's exact test. Multivariable linear regression was used to evaluate characteristics associated with lower financial toxicity.Results: Overall, 281 patients met inclusion criteria of which 79 reported high financial toxicity. In multivariable analysis, characteristics associated with lower financial toxicity included older age (estimate:0.36, 95%CI:0.21-0.52), applying for patient assistance programs (estimate:4.42, 95%CI:1.72-7.11), and an annual income of at least $100,000 (estimate:7.81, 95%CI:0.97,14.66). Patients with high financial toxicity were more likely to decrease spending on basic goods (35% vs. 2.5%, p0.001), as well as use savings (62% vs. 17%, p<0.001) to pay for their treatment.Conclusions: In this cross-sectional study, patients with metastatic prostate cancer and high financial toxicity were more likely to decrease spending on basic goods and leisure activities and use savings to pay for care. Understanding the impact of financial toxicity on patients' lives is crucial to inform shared decision-making and interventions designed to mitigate financial toxicity in this population.
533 $a Electronic reproduction. $b Ann Arbor, Mich. : $c ProQuest, $d 2024
538 $a Mode of access: World Wide Web
650 4 $a Oncology. $3 593951
650 4 $a Biomedical engineering. $3 588770
650 4 $a Health sciences. $3 1179212
653 $a Financial toxicity
653 $a Healthcare delivery
653 $a Prostate cancer
653 $a Metastatic disease
653 $a Fisher's exact test
655 7 $a Electronic books. $2 local $3 554714
690 $a 0566
690 $a 0541
690 $a 0992
710 2 $a College of Medicine - Mayo Clinic. $b Clinical and Translational Science. $3 1194551
710 2 $a ProQuest Information and Learning Co. $3 1178819
773 0 $t Masters Abstracts International $g 85-03.
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30639261 $z click for full text (PQDT)